Ardelyx (ARDX) Assets Average (2014 - 2026)
Ardelyx (ARDX) posted Assets Average of $503.1 million for Q1 2026, up 1.86% on a QoQ basis from $493.9 million in Q4 2025, and up 18.93% year-over-year from $423.0 million in Q1 2025.
Ardelyx (ARDX) Assets Average (2014 - 2026) Analysis & Trends
Ardelyx's Assets Average history runs 13 years deep, the most recent figure standing at $503.1 million for Q1 2026.
- Quarterly Assets Average rose 18.93% year-over-year to $503.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $503.1 million (up 18.93% YoY) and the FY2025 annual result came in at $468.7 million, up 27.82% from the prior year.
- Assets Average was $503.1 million for Q1 2026 at Ardelyx, up from $493.9 million in the prior quarter.
- Across five years, Assets Average topped out at $503.1 million in Q1 2026 and bottomed at $130.5 million in Q2 2022.
- A 5-year average of $311.3 million and a median of $320.0 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average sank 37.15% — and 2023, when it jumped 81.19%.
- Ardelyx's Assets Average stood at $167.4 million in 2022, then jumped by 75.35% to $293.5 million in 2023, then surged by 36.91% to $401.8 million in 2024, then gained by 22.92% to $493.9 million in 2025, then grew by 1.86% to $503.1 million in 2026.
- Business Quant data shows ARDX's Assets Average at $503.1 million in Q1 2026, $493.9 million in Q4 2025, and $476.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 503.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 503.06 Mn |
| Dec 31, 2025 | 493.89 Mn |
| Sep 30, 2025 | 476.47 Mn |
| Jun 30, 2025 | 438.48 Mn |
| Mar 31, 2025 | 422.97 Mn |
| Dec 31, 2024 | 401.81 Mn |
| Sep 30, 2024 | 355.68 Mn |
| Jun 30, 2024 | 342.94 Mn |
| Mar 31, 2024 | 319.98 Mn |
| Dec 31, 2023 | 293.48 Mn |
| Sep 30, 2023 | 250.29 Mn |
| Jun 30, 2023 | 214.11 Mn |
| Mar 31, 2023 | 203.54 Mn |
| Dec 31, 2022 | 167.37 Mn |
| Sep 30, 2022 | 138.14 Mn |
| Jun 30, 2022 | 130.51 Mn |
| Mar 31, 2022 | 139.66 Mn |
| Dec 31, 2021 | 160.38 Mn |
| Sep 30, 2021 | 187.92 Mn |
| Jun 30, 2021 | 207.64 Mn |